Your browser is no longer supported. Please, upgrade your browser.
RMED Ra Medical Systems, Inc. daily Stock Chart
Ra Medical Systems, Inc.
Index- P/E- EPS (ttm)-1.74 Insider Own28.00% Shs Outstand18.83M Perf Week-10.84%
Market Cap74.38M Forward P/E- EPS next Y-0.12 Insider Trans- Shs Float7.36M Perf Month-45.89%
Income-19.00M PEG- EPS next Q-0.29 Inst Own32.20% Short Float12.74% Perf Quarter-50.44%
Sales6.20M P/S12.00 EPS this Y78.10% Inst Trans-1.62% Short Ratio15.27 Perf Half Y-
Book/sh0.79 P/B5.00 EPS next Y83.60% ROA- Target Price20.75 Perf Year-
Cash/sh0.26 P/C15.18 EPS next 5Y- ROE- 52W Range3.76 - 22.00 Perf YTD-50.31%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-82.05% Beta-
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin24.80% 52W Low5.05% ATR0.54
Employees95 Current Ratio1.10 Sales Q/Q-19.20% Oper. Margin- RSI (14)19.09 Volatility9.59% 10.16%
OptionableNo Debt/Eq0.00 EPS Q/Q47.80% Profit Margin- Rel Volume1.45 Prev Close4.18
ShortableYes LT Debt/Eq0.00 EarningsMar 14 AMC Payout- Avg Volume61.40K Price3.95
Recom2.00 SMA20-35.32% SMA50-45.42% SMA200-55.65% Volume89,152 Change-5.50%
Nov-02-18Initiated Maxim Group Buy $23
Mar-14-19 04:05PM  Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results Business Wire
Mar-07-19 04:30PM  New Study Shows DABRA Laser System Achieved 94% Success Rate in Patients with Peripheral Artery Disease Business Wire
07:00AM  Ra Medical to Hold 2018 Fourth Quarter and Full Year Conference Call on March 14, 2019 Business Wire
Feb-20-19 08:30AM  New Data Presented at LINC 2019 Demonstrates Acute Success with DABRA Excimer Laser System for the Treatment of Peripheral Artery Disease Business Wire
Jan-02-19 08:00AM  Ra Medical Systems to Present at Biotech Showcase 2019 on January 8 during Annual JPMorgan Healthcare Conference in San Francisco Business Wire
Dec-26-18 02:59PM  Analysts Expect Breakeven For Ra Medical Systems, Inc. (NYSE:RMED) Simply Wall St.
Dec-17-18 08:00AM  Ra Medical Systems Appoints Thomas Fogarty as Chief Commercial Officer Business Wire
Nov-13-18 04:15PM  Ra Medical Systems Reports Third Quarter 2018 Results Business Wire
Oct-30-18 04:15PM  Ra Medical Systems to Report Third Quarter 2018 Results on November 13, 2018 Business Wire
Oct-24-18 04:15PM  Ra Medical Systems Appoints Dan Horwood as General Counsel Business Wire
Oct-01-18 05:03PM  Ra Medical Systems Announces Closing of Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares Business Wire -18.63%
Sep-27-18 03:09PM  Ra Medical's stock soars to pace NYSE gainers after public debut MarketWatch
Sep-26-18 11:13PM  Ra Medical Systems Announces Pricing of Initial Public Offering Business Wire
Sep-22-18 04:15PM  The IPO Outlook For The Week: Smart Appliances, A Language App and Drugmakers Benzinga
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.